Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 06, 2026
Why Is Datadog (DDOG) Stock Down -17.78% Today?

Why Is Datadog (DDOG) Stock Down -17.78% Today?

Key Takeaways

  • Datadog shares plunged approximately 17.78% on Thursday, marking the largest single-day decline in the company's history, falling from Wednesday's record close of $283.17 to around $232.82 in early trading.
  • The primary catalyst was a "sell-the-news" reaction to the company's Q2 2026 earnings report, which beat on both revenue and earnings per share but failed to satisfy elevated investor expectations after a massive run-up.
  • Secondary drivers included valuation concerns, with the stock trading at stretched multiples even after the selloff, a Jefferies downgrade to Hold, and recent insider selling.
  • The move was company-specific rather than macro-driven, with the Nasdaq down only modestly and the S&P 500 slightly positive, underscoring that the selloff reflected Datadog-specific dynamics.
  • Traders are now watching whether the stock can stabilize above key technical levels and how analyst sentiment evolves following the post-earnings revaluation.

Opening Summary

DDOG, the cloud-native observability and security platform provider Datadog, Inc., saw its shares crater approximately 17.78% in Thursday's trading session, tumbling from a previous close of $283.17 to roughly $232.82. The stock, which had closed at an all-time high just one day earlier, suffered its steepest single-day percentage decline on record. The selloff came despite Datadog reporting second-quarter results that surpassed Wall Street estimates on nearly every metric and raising its full-year guidance — a clear case of elevated expectations colliding with an already-priced-to-perfection stock.

Earnings Beat Meets Sky-High Expectations

Datadog's Q2 2026 results were objectively strong. The company delivered adjusted earnings of $0.65 per share, well above the $0.58 consensus estimate. Revenue climbed 36% year-over-year to $1.12 billion, exceeding the $1.08 billion Wall Street was modeling. Billings surged 38% to $1.18 billion, also ahead of forecasts. The company ended the quarter with approximately 4,720 customers generating over $100,000 in annual recurring revenue, up 23% from a year earlier.

Management raised its full-year revenue outlook to a range of $4.45 billion to $4.47 billion, up from the prior $4.30 billion to $4.34 billion, and lifted EPS guidance to $2.50–$2.54. Third-quarter guidance likewise came in above consensus on both the top and bottom lines.

Yet the market punished the stock. The reason lies in the setup: DDOG had rallied roughly 107% over the preceding 12 months and more than 110% year-to-date, blasting through multiple all-time highs. Dozens of analysts had raised estimates and price targets in the days leading into the report. Simply beating estimates was not enough — investors wanted a blowout that justified the extreme valuation premium.

Valuation Reality Check After a 107% Rally

Even after Thursday's sharp decline, Datadog's valuation remains a central point of debate. At Wednesday's close of $283.17, the stock traded at a forward P/E of roughly 113x. After the drop, that multiple compressed to approximately 89x — still extremely elevated for a company with a market capitalization above $100 billion. Multiple fair-value models peg Datadog's intrinsic value significantly below its current trading price, with some estimates around the $193–$195 range, suggesting further potential downside if momentum continues to unwind.

The stock's meteoric rise had placed it firmly in overbought territory by multiple technical measures heading into earnings. A weekly RSI above 74 and daily stochastic RSI above 81 signaled that the rally was stretched, leaving shares vulnerable to any perceived disappointment. The drop also breached key moving averages, including the 50-day moving average near $249, and gapped well below a recent breakout buy point of $276.70.

Analyst Sentiment and Insider Activity

Adding to the pressure, Jefferies downgraded DDOG to Hold ahead of earnings, arguing that the AI beneficiary thesis powering the stock's surge was "largely played out" at current valuation levels. While the broader analyst consensus remains bullish — with firms including Cantor Fitzgerald, Rosenblatt, and Citigroup recently raising price targets as high as $327 — the downgrade underscored growing unease about the sustainability of the premium multiple.

Insider activity also raised eyebrows. A company director sold approximately $4.9 million worth of shares in the week before earnings, and total insider selling over the past three months reportedly exceeded $389 million, with no insider purchases recorded during that period. Such patterns, while not unusual for a highly appreciated stock, can weigh on sentiment when the narrative turns cautious.

Market Context and Trading Activity

The selloff in DDOG was notably company-specific rather than a function of broad market weakness. The Nasdaq Composite edged only modestly lower on Thursday, while the S&P 500 was roughly flat, indicating that the plunge was not driven by a rotation out of technology or software stocks more broadly. Trading volume in Datadog was exceptionally elevated, far surpassing its daily average, as institutional and retail investors alike scrambled to reposition following the earnings release.

The stock's beta of approximately 1.51 amplified the move, meaning that any directional momentum — whether driven by fundamentals or sentiment — tends to be magnified relative to the broader market. For a name that had become a consensus long among growth-focused and AI-thematic investors, the unwind was swift and punishing.

What Comes Next for DDOG

Looking ahead, the focus will shift to whether Datadog's underlying business momentum can eventually reassert itself and stabilize the stock. The company's fundamentals remain robust: 36% revenue growth, expanding enterprise customer relationships, strong free cash flow generation, and a clear tailwind from AI infrastructure monitoring demand all support the long-term thesis. CEO Olivier Pomel emphasized that "customers are building and deploying with AI, and they are using the Datadog platform to observe, secure, and act on their AI-enabled solutions."

However, risks remain. The potential for OpenAI — currently a Datadog customer — to build in-house observability tools has surfaced as a competitive overhang. Broader macro uncertainty and the possibility of further mean reversion in high-multiple growth stocks also present headwinds. The next major catalysts will include the Q3 earnings report and any updates on large enterprise deal momentum, both of which will be critical in determining whether Thursday's selloff was a buying opportunity or the start of a deeper reset.

Trending AI Robots

For traders seeking to navigate volatile market environments with data-driven precision, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots. Tickeron provides hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this section. Bots vary by strategy, timeframe, performance metrics, and traded symbols, allowing users to explore automated approaches tailored to different market regimes. Discover which AI trading bots are currently leading the pack by visiting the Trending AI Robots page and see how algorithmic strategies can complement your market analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: DDOG

Momentum Indicator for DDOG turns positive, indicating new upward trend

DDOG saw its Momentum Indicator move above the 0 level on July 30, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 77 similar instances where the indicator turned positive. In of the 77 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for DDOG just turned positive on August 03, 2026. Looking at past instances where DDOG's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DDOG advanced for three days, in of 317 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 229 cases where DDOG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for DDOG moved out of overbought territory on August 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DDOG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

DDOG broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DDOG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (25.253) is normal, around the industry mean (27.954). DDOG's P/E Ratio (726.077) is considerably higher than the industry average of (81.868). Projected Growth (PEG Ratio) (1.768) is also within normal values, averaging (1.680). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (28.090) is also within normal values, averaging (52.021).

Notable companies

The most notable companies in this group are Shopify Inc (NASDAQ:SHOP), Salesforce (NYSE:CRM), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Adobe (NASDAQ:ADBE), Datadog (NASDAQ:DDOG), Intuit (NASDAQ:INTU), Autodesk (NASDAQ:ADSK), Workday (NASDAQ:WDAY), Zoom Communications Inc (NASDAQ:ZM).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 10.01B. The market cap for tickers in the group ranges from 291 to 222.3B. SAP holds the highest valuation in this group at 222.3B. The lowest valued company is BLGI at 291.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was 7%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 6%. YXT experienced the highest price growth at 686%, while YAAS experienced the biggest fall at -85%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was 19%. For the same stocks of the Industry, the average monthly volume growth was 47% and the average quarterly volume growth was -24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 77
Price Growth Rating: 57
SMR Rating: 78
Profit Risk Rating: 94
Seasonality Score: -5 (-100 ... +100)
View a ticker or compare two or three
DDOG
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company, which engages in the development of monitoring and analytics platform for developers, information technology operations teams and business users

Industry PackagedSoftware

Profile
Details
Industry
N/A
Address
620 8th Avenue
Phone
+1 866 329-4466
Employees
8100
Web
https://www.datadog.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.